A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
NCT00672867 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2014-12-18
Summary
The purpose of this study is to compare the safety and antiviral activity of Clevudine Versus Adefovir dipivoxil in patients with LC-B.
Conditions
- Patients With LC-B
Interventions
- DRUG
-
Clevudine
30mg
- DRUG
-
Adefovir dipivoxil
10mg
Sponsors & Collaborators
-
Bukwang Pharmaceutical
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2012-11-30
- Completion
- 2014-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
NCT00313287 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
NCT00362505 ·Status: TERMINATED ·Phase: PHASE3
-
Long-term Study With Clevudine
NCT00558818 ·Status: COMPLETED ·Phase: PHASE4
-
A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC
NCT01263002 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
NCT00044135 ·Status: UNKNOWN ·Phase: PHASE2
-
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
NCT00362635 ·Status: COMPLETED ·Phase: PHASE3
-
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
NCT00558493 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
NCT00305019 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
NCT00313261 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
NCT00313274 ·Status: TERMINATED ·Phase: PHASE3
-
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
NCT00823342 ·Status: TERMINATED ·Phase: PHASE3
-
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
NCT00076336 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
NCT01264367 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
NCT00496158 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
NCT00496002 ·Status: TERMINATED ·Phase: PHASE3
-
Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B
NCT02482272 ·Status: UNKNOWN ·Phase: PHASE4
-
An Study of Efficacy and Safety of Clevudine
NCT01192854 ·Status: COMPLETED ·Phase: PHASE3
-
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B
NCT01270165 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
NCT00501124 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
NCT01264094 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study
NCT01804387 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients
NCT01266005 ·Status: TERMINATED ·Phase: PHASE4
-
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
NCT00531167 ·Status: COMPLETED ·Phase: PHASE4
-
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
NCT01732367 ·Status: COMPLETED ·Phase: PHASE4